Stemline Therapeutics, Inc. to Present at BIO CEO & Investor Conference on February 11th
[at noodls] – NEW YORK, Feb. 7, 2013 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) … more
View todays social media effects on STML
View the latest stocks trending across Twitter. Click to view dashboard